| 生物活性 | |||
|---|---|---|---|
| 靶点 |
|
||
| 描述 | Spironolactone is a potent antagonist of the androgen receptor with IC50 of 77 nM. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01944384 | Diastolic Heart Failure | Phase 4 | Completed | - | - |
| NCT00123955 | Diastolic Heart Failure ... 展开 >> Heart Failure, Congestive 收起 << | Phase 3 | Completed | - | United States, North Carolina ... 展开 >> Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 收起 << |
| NCT00123955 | - | Completed | - | - | |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.40mL 0.48mL 0.24mL |
12.00mL 2.40mL 1.20mL |
24.01mL 4.80mL 2.40mL |
| 参考文献 |
|---|